STING1 and neoplasm: Clinical relevance was assessed through a retrospective analysis of cohorts of patients with PDAC and immunohistochemical evaluation of STING expression in tumor tissues.<h4>Results</h4>The AGP regimen confers promising potential to AG regimen in patients with PDAC as well as in PDAC mouse models.